G‐CSF induces CD15(+) CD14(+) cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironment

OBJECTIVES: Recombinant granulocyte colony‐stimulating factor (G‐CSF) is frequently administered to patients with cancer to enhance granulocyte recovery post‐chemotherapy. Clinical trials have also used G‐CSF to modulate myeloid cell function in pregnancy and inflammatory diseases. Although the cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Maneta, Ebtehag, Fultang, Livingstone, Taylor, Jemma, Pugh, Matthew, Jenkinson, William, Anderson, Graham, Coomarasamy, Arri, Kilby, Mark D, Lissauer, David M, Mussai, Francis, De Santo, Carmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114661/
https://www.ncbi.nlm.nih.gov/pubmed/35602884
http://dx.doi.org/10.1002/cti2.1395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114661/
https://www.ncbi.nlm.nih.gov/pubmed/35602884
http://dx.doi.org/10.1002/cti2.1395

Ejemplares similares